FEATURED TRIALS
Graves' Disease | BHV-1300
Life With Graves' Disease Deserves a Better Answer
Drug: BHV-1300
Age: 18-70
Phase: 3
Advanced or Metastatic Solid Tumors
BHV-1530 is being studied to see if it is safe and effective for patients with advanced or metastatic solid tumors
Drug: BHV-1530
Age: 18-95
Phase: 1
IgA Nephropathy
Researching the safe and effective treatment of BHV-1400 for patients with IgA nephropathy (IgAN)
Drug: BHV-1400
Age: 18-65
Phase: 1
Graves' Disease | BHV-1300
We're conducting a study to see if BHV-1300 is a safe treatment for people with Graves' disease
Drug: BHV-1300
Age: 18-65
Phase: 1b
Parkinson's Disease
Researching an investigational treatment to change the course of Parkinson's disease
Drug: BHV-8000
Age: 40-80
Phase: 2/3
FOCAL EPILEPSY
Researching an investigational treatment option for focal onset epilepsy
Drug: BHV-7000
Age: 18-75
Phase: 2/3